Dr. Lal Path Labs Ltd. (LALPATHLAB) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.134x

Based on the latest financial reports, Dr. Lal Path Labs Ltd. (LALPATHLAB) has a cash flow conversion efficiency ratio of 0.134x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.24 Billion ≈ $35.04 Million USD) by net assets (Rs24.22 Billion ≈ $261.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see LALPATHLAB company net worth for the company's overall valuation and market capitalisation.

Dr. Lal Path Labs Ltd. - Cash Flow Conversion Efficiency Trend (2011–2026)

This chart illustrates how Dr. Lal Path Labs Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Dr. Lal Path Labs Ltd. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dr. Lal Path Labs Ltd. ranked by their cash flow conversion efficiency. Explore cash flow quality index of Dr. Lal Path Labs Ltd. to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
National Health Investors Inc NYSE:NHI	0.035x
The a2 Milk Company Ltd AU:A2M	0.069x
Highwoods Properties Inc NYSE:HIW	0.048x
Constellium SE F:3OK	0.128x
GZ Port SHG:601228	0.010x
Uxi Unicomp Technology Co. Ltd. A SHG:688531	N/A
Sims Ltd AU:SGM	0.062x
Viohalco S.A BR:VIO	0.050x

Annual Cash Flow Conversion Efficiency for Dr. Lal Path Labs Ltd. (2011–2026)

The table below shows the annual cash flow conversion efficiency of Dr. Lal Path Labs Ltd. from 2011 to 2026. View Dr. Lal Path Labs Ltd. (LALPATHLAB) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs25.41 Billion ≈ $274.83 Million	Rs7.02 Billion ≈ $75.92 Million	0.276x	+7.16%
2025-03-31	Rs22.07 Billion ≈ $238.62 Million	Rs5.69 Billion ≈ $61.51 Million	0.258x	-9.21%
2024-03-31	Rs18.85 Billion ≈ $203.89 Million	Rs5.35 Billion ≈ $57.89 Million	0.284x	+5.82%
2023-03-31	Rs17.00 Billion ≈ $183.79 Million	Rs4.56 Billion ≈ $49.31 Million	0.268x	-7.28%
2022-03-31	Rs15.44 Billion ≈ $166.93 Million	Rs4.47 Billion ≈ $48.31 Million	0.289x	-7.25%
2021-03-31	Rs12.76 Billion ≈ $138.00 Million	Rs3.98 Billion ≈ $43.06 Million	0.312x	+15.85%
2020-03-31	Rs10.54 Billion ≈ $113.99 Million	Rs2.84 Billion ≈ $30.70 Million	0.269x	+17.20%
2019-03-31	Rs9.51 Billion ≈ $102.84 Million	Rs2.19 Billion ≈ $23.63 Million	0.230x	-7.30%
2018-03-31	Rs7.95 Billion ≈ $85.97 Million	Rs1.97 Billion ≈ $21.31 Million	0.248x	-4.36%
2017-03-31	Rs6.62 Billion ≈ $71.61 Million	Rs1.72 Billion ≈ $18.56 Million	0.259x	-10.07%
2016-03-31	Rs5.10 Billion ≈ $55.10 Million	Rs1.47 Billion ≈ $15.88 Million	0.288x	+1.14%
2015-03-31	Rs3.43 Billion ≈ $37.14 Million	Rs978.50 Million ≈ $10.58 Million	0.285x	-32.12%
2014-03-31	Rs2.33 Billion ≈ $25.23 Million	Rs979.58 Million ≈ $10.59 Million	0.420x	-22.03%
2013-03-31	Rs1.64 Billion ≈ $17.70 Million	Rs881.31 Million ≈ $9.53 Million	0.538x	-7.47%
2012-03-31	Rs1.17 Billion ≈ $12.66 Million	Rs681.28 Million ≈ $7.37 Million	0.582x	+30.20%
2011-03-31	Rs934.94 Million ≈ $10.11 Million	Rs417.87 Million ≈ $4.52 Million	0.447x	--

About Dr. Lal Path Labs Ltd.

NSE:LALPATHLAB India Diagnostics & Research

Market Cap

$3.43 Billion

Rs317.58 Billion INR

Market Cap Rank

#4560 Global

#200 in India

Share Price

Rs1901.90

Change (1 day)

+1.30%

52-Week Range

Rs1307.60 - Rs3473.50

All Time High

Rs4119.53